Safety and immunogenicity of a bivalent SARS-CoV-2 recombinant protein vaccine, SCTV01C in unvaccinated adults: A randomized, double-blinded, placebo-controlled, phase I clinical trial

Detalles Bibliográficos
Autores principales: Wang, Guiqiang, Zhao, Kexin, Han, Jun, Hu, Zhongyu, Zhang, Tianzuo, Wang, Yanchao, Shi, Rui, Li, Yanhua, Song, Qinqin, Du, Haijun, He, Peng, Xu, Shuping, Yang, Xinjie, Fu, Yongpan, Cui, Yimin, Xie, Liangzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Infection Association. Published by Elsevier Ltd. 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672836/
https://www.ncbi.nlm.nih.gov/pubmed/36403700
http://dx.doi.org/10.1016/j.jinf.2022.11.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672836/
https://www.ncbi.nlm.nih.gov/pubmed/36403700
http://dx.doi.org/10.1016/j.jinf.2022.11.008

Ejemplares similares